LOS ANGELES, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation has recently announced the appointment of Dr. Poornima Parameswaran, the Chief Executive Officer, and Co-founder of Trace Genomics, to its board. Poornima is a three-year myeloma warrior. This appointment underscores IMF's ongoing commitment to bridge cutting-edge science and innovation with an entrepreneurial mindset and patient-centered advocacy in the fight against myeloma.
Dr. Parameswaran has had a distinguished career as a scientist and entrepreneur. Her journey has been characterized by resilience, innovation, and a deep commitment to advancing science for a healthier planet. Over the course of her career, she has demonstrated her ability to lead dynamic teams through transformative change.